MedPath

Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE

Completed
Conditions
sRAGE Level
SUV and TBR Levels in FDG PET
Registration Number
NCT01021514
Lead Sponsor
Korea University
Brief Summary

Arteriosclerosis is a dynamic inflammatory disorder. Recently, FDG-PET CT is emerging diagnostic tool of non-invasive technique to detect vulnerable atherosclerotic plaque. And there are arising evidence that sRAGE(soluble Receptor for Advanced glycation End Product) is correlated with metabolic risk. So the investigators will investigate association between sRAGE and FDG-PET uptake in large artery in healthy patient.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
82
Inclusion Criteria
  • Clinical diagnosis od type 2 DM
Exclusion Criteria
  • Type 1 DM
  • Gestational Diabetes
  • Severe Liver or Renal disease
  • Diagnosis of cancer
  • Trauma
  • Acute infection or inflammatory disease
  • Acute vasculitis or history of vasculitis
  • Pregnant or Lactating women
  • Dyslipidemia(active state)
  • Cardiovascular disease or history of CVD
  • Chronic obstructive pulmonary disease
  • Any patient by judge of investigator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath